These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6013814)

  • 1. [Clinical, electroencephalographic and biochemical aspects of the 1-dopa effect].
    Bente D; Stoerger R; Tautz NA
    Arzneimittelforschung; 1966 Feb; 16(2):265-7. PubMed ID: 6013814
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of L-dihydroxyphenylalanine by patients with Parkinson's disease.
    Tyce GM; Muenter MD; Owen CA
    Mayo Clin Proc; 1970 Sep; 45(9):645-56. PubMed ID: 5311767
    [No Abstract]   [Full Text] [Related]  

  • 3. The excretion of L-dopa metabolites at different hours of the day.
    Aguggini G; Meucci M; Reina G
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):749-57. PubMed ID: 4629113
    [No Abstract]   [Full Text] [Related]  

  • 4. Imipramine-mediated effects on levodopa metabolism in man.
    Messiha FS; Morgan JP
    Biochem Pharmacol; 1974 May; 23(10):1503-7. PubMed ID: 4847533
    [No Abstract]   [Full Text] [Related]  

  • 5. [The excretion of vanilmandelic acid, vanillic acid, homovanillic acid and 5-hydroxyindoleacetic acid by urine in smokers and non-smokers].
    Schmid E; Tautz NA; Bauersachs E; Krautheim J
    Arzneimittelforschung; 1968 Jul; 18(7):819-21. PubMed ID: 5755826
    [No Abstract]   [Full Text] [Related]  

  • 6. [Further clinical-experimental studies on the question of central anticholinergic agent induced confusional states].
    Bente D; Stoerger R; Tautz NA
    Arzneimittelforschung; 1966 Feb; 16(2):231-3. PubMed ID: 4383293
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose-related alterations in metabolism of levodopa: possible mechanism for hypotensive effect.
    Kochar MS; Itskovitz HD; Sasse EA; Baker JD; Doumas BT
    J Clin Pharmacol; 1974; 14(8):448-54. PubMed ID: 4851433
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of 3,4-dihydroxyphenylalanine (L-dopa) in human subjects.
    Goodall M; Alton H
    Biochem Pharmacol; 1972 Sep; 21(17):2401-8. PubMed ID: 4647074
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
    Imai K; Sugiura M; Kubo H; Tamura Z; Oya K
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):759-64. PubMed ID: 5045616
    [No Abstract]   [Full Text] [Related]  

  • 10. Gas-liquid chromatographic study and estimation of several urinary aromatic acids.
    Horning MG; Knox KL; Dalgliesh CE; Horning EC
    Anal Biochem; 1966 Nov; 17(2):244-57. PubMed ID: 5971420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Simple test for pheochromocytoma as well as neuroblastoma and small intestine carcinoids. Analysis of 3-methoxy-4-hydroxymandelic acid, 3-methoxy-4-hydroxyphenylacetic acid and 5-hydroxy-indoleacetic acid in urine by chromatoelectrophoresis].
    Lachhein L; Schütz J
    Clin Chim Acta; 1967 Mar; 15(3):429-34. PubMed ID: 6034419
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the mode of action of prenylamine (Segontin) and other coronary dilating drugs in man.
    Schmid E; Bachmann K; Krautheim J; Heynen HP
    Indian Heart J; 1968 Apr; 20(2):133-40. PubMed ID: 5738423
    [No Abstract]   [Full Text] [Related]  

  • 13. Fine structural and biochemical studies on the malignant ganglioneuroma.
    Staley NA; Poleksy HF; Bensch KG
    J Neuropathol Exp Neurol; 1967 Oct; 26(4):634-53. PubMed ID: 6053734
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of tranylcypromine and trifluoperazine (Jatrosom) addiction: psychopathological, sleep physiology and biochemical investigations].
    Cramer H; Ohlmeier D
    Arch Psychiatr Nervenkr (1970); 1967; 210(2):182-97. PubMed ID: 6057356
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the mechanism of action of a new cardiac beta-aminoketone. Behavior of the metabolism of biogenic amines in humans].
    Krautheim J; Schmid E
    Arzneimittelforschung; 1966 Nov; 16(11):1500-2. PubMed ID: 6014966
    [No Abstract]   [Full Text] [Related]  

  • 16. The urinary elimination of vanillyl mandelic acid and 5-hydroxyindoleacetic acid in healthy Puerto Ricans.
    Suárez RM; Alvarado F; Suárez RM; Olavarrieta S
    Bol Asoc Med P R; 1967 May; 59(5):216-21. PubMed ID: 5232816
    [No Abstract]   [Full Text] [Related]  

  • 17. [Simultaneous evaluation by gas chromatography of urinary acids: homovanillic, vanilmandelic, indoleacetic and 5 hydroxyindoleacetic].
    Ruíz-González MC; Arranz MI
    Rev Clin Esp; 1980 Aug 15-31; 158(3-4):139-43. PubMed ID: 6159668
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of the cigarette smoking hibit on urinary elimination of tryptamine, 5-hydroxy-indolacetic acid and 3-methoxy-4-hydroxy-mandelic acid in healthy young women].
    Periti P; Gasparri F; Santini D
    Boll Soc Ital Biol Sper; 1966 Aug; 42(15):954-7. PubMed ID: 5969314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the effect of smoking on the urinary excretion of the metabolites of biogenic amines].
    Schmid E; Tautz NA; Winter P; Zicha L
    Verh Dtsch Ges Inn Med; 1965; 71():701-4. PubMed ID: 5877690
    [No Abstract]   [Full Text] [Related]  

  • 20. [Excretion of 5-hydroxyindoleacetic acid and vanilmandelic acid in patients with glaucoma].
    Dienstbier E; Balík J; Duchon J; Fischer O
    Cesk Oftalmol; 1967 May; 23(3):177-86. PubMed ID: 5586682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.